A phase II study of docetaxel weekly in combination with carboplatin every three weeks as first line chemotherapy in stage IIB-IV epithelial ovarian cancer: Neurological toxicity and quality-of-life evaluation

By                  

International Journal of Oncology, Vol. 40, Iss. 3, 2012-01 ,pp. : 773-781

Spandidos Publications

Access to resources Recommend Favorite

First-Line Chemotherapy with Weekly Paclitaxel and Carboplatin for Advanced Ovarian Cancer: A Phase I Study

By Sehouli J.   Stengel D.   Elling D.   Ortmann O.   Blohmer J.   Riess H.   Lichtenegger W.  

Gynecologic Oncology, Vol. 85, Iss. 2, 2002-05 ,pp. : 321-326

Academic Press

Access to resources Recommend Favorite

Weekly chemotherapy with carboplatin, docetaxel and irinotecan in advanced non-small-cell-lung cancer - a phase II study

By Pectasides D.   Visvikis A.   Kouloubinis A.   Glotsos J.   Bountouroglou N.   Karvounis N.   Ziras N.   Athanassiou A.  

European Journal of Cancer, Vol. 38, Iss. 9, 2002-06 ,pp. : 1194-1200

Elsevier

Access to resources Recommend Favorite

First-line chemotherapy with epidoxorubicin, paclitaxel, and carboplatin for the treatment of advanced epithelial ovarian cancer patients

By Romanini A.   Tanganelli L.   Carnino F.   Fanucchi A.   Lionetto R.   Pastorino S.   Cosio S.   Gadducci A.   Conte P.F.  

Gynecologic Oncology, Vol. 89, Iss. 3, 2003-06 ,pp. : 354-359

Elsevier

Access to resources Recommend Favorite

A pilot study of docetaxel-carboplatin versus paclitaxel-carboplatin in Japanese patients with epithelial ovarian cancer

By Mori Taisuke   Hosokawa Kenichi   Kinoshita Yoshiyuki   Watanabe Ai   Yamaguchi Takeshi   Kuroboshi Haruo   Kato Yoshiko   Yasuda Jinsuke   Fujita Hiroyuki   Nakata Yoshinori   Honjo Hideo  

International Journal of Clinical Oncology, Vol. 12, Iss. 3, 2007-06 ,pp. : 205-211

Springer Publishing Company

Access to resources Recommend Favorite